Abstract
Opioid agonists were used to investigate the modulation of seizures in the seizure-susceptible El mouse. Morphine andd-Ala2-d-Leu5-enkephalin (DADLE) were injected subcutaneously or intracisternally as prototypic agonists for μ and δ opioid receptors. Systemic or intracisternal injection of both morphine and DADLE decreased the incidence of seizures and the seizure score in El mice in a dose-dependent manner. The anticonvulsant effects of morphine and DADLE were reversed by naloxone (2 mg/kg, s.c.). This implies that opioid agonists have anticonvulsant properties which are mediated by μ and δ opioid receptors. In conclusion, a deficit in endogenous opioid peptides, which act as anticonvulsants may play a significant role in the etiology or pathophysiology of seizures in the El mouse.
Similar content being viewed by others
References
Frederickson, R. C. A., and Chipkin, R. E. 1988. Endogenous opioids and pain: Status of human studies and new treatment concepts. Prog. Brain Res. 77:407–417.
Grossman, A. 1985. Opioids and stress in man. J. Endocrinol. 119:377–381.
Reid, L. D. 1985. Endogenous opioid peptides and regulation of drinking and feeding. Am. J. Clin. Nutr. 42:1099–1132.
Urca, G., Frenk, H., Liebeskind, J. C., and Taylor, A. N. 1977. Morphine and enkephalin: Analgesic and epileptic properties. Science 197:83–86.
Henriksen, S. J., Bloom, F. E., Ling, N., and Guillemin, R. 1977. Induction of limbic scizures by endorphins and opiate alkaloids: Electrophysiological and behavioral correlates. Soc. Neurosci. Abstr. 3:293.
Tortella, F. C., Echevarria, E., Lipkowski, A. W., Takemori, A. E., Portoghese, P. S., and Holaday, J. W. 1989. Selective kappa antagonist properties of nor-binaltorphimine in the rat MES seizure model. Life Sci. 44:661–665.
Tortella, F. C., Robles, L., Echevarria, E., Hunter, J. C., and Hughes, J. 1990. PD117302, a selective nonpeptide opioid kappa agonist, protects against NMDA and maximal electroshock convulsions in rats. Life Sci. 46:PL1–7.
Tortella, F. C., Cowan, A., and Adler, M. W. 1981. Comparison of the anticonvulsant effects of opioid peptides and etorphine in rats after ICV administration. Life Sci. 10:1039–1045.
Tortella, F. C. 1988. Endogenous opioid peptides and epilepsy: quieting the seizing brain? Trends Pharmacol. Sci. 9:366–372.
Frenk, H. 1983. Pro-and anticonvulsant actions of morphine and the endogenous opioids: Involvement and interactions of multiple opiate and non-opiate systems. Brain Res. Rev. 6:197–210.
Albertson, T. E., Joy, R. M., and Stark, L. G. 1984. Modification of kindled amygdaloid seizures by opiate agonists and antagonists. J. Pharmacol. Exp. Ther. 228:620–627.
McNamara, J. O., Bonhaus, D. W., Shin, C., Crain, B. J., Gellman, R. L., and Giaccino, J. L. 1985. The kindling model of epilepsy: A critical review CRC Crit. Rev. Clin. Neurobiol. 1:341–391.
Stone, W. S., Eggleton, C. E., and Berman, R. F. 1982. Opiate modification of amygdaloid-kindled seizures in rats. Pharmacol. Biochem. Behav. 16:751–756.
Chen, C. S., Gates, G. R., and Reynoldson, J. A. 1976. Effect of morphine and naloxone on priming-induced audiogenic seizures in BALB/c mice. Br. J. Pharmacol. 58:517–520.
Meldrum, B. S., Menini, Ch., Stutzmann, J. M., and Naquet, R. 1979. Effects of opiate-like peptides, morphine, and naloxone in the photosensitive baboon, papio papio. Brain Res. 170:333–348.
Bajorek, J. G., and Lomax, P. 1982. Modulation of spontaneous seizures in the Mongolian gerbil: Effects of β-endorphin. Peptides 3:83–86.
Lee, R. J., Bajorek, J. G., and Lomax, P. 1983. Opioid peptides and seizures in the spontaneously epileptic Mongolian gerbil. Life Sci. 33:567–570.
Lee, R. J., Bajorek, J. G., and Lomax, P. 1984. Similar anticonvulsant, but unique behavioural effects of opioid agonists in the seizure-sensitive Mongolian gerbil. Neurophamacology. 23:517–524.
Seyfried, T. N., and Glaser, G. H. 1985. A review of mouse mutants as genetic models of epilepsy. Epilepsia 26:143–150.
Mori, A. 1988. El mice: Neurochemical approach to the seizure mechanism. Neurosciences 14:275–285.
Suzuki, J. 1976. Paroxysmal discharges in the electroencephalogram of the El mouse. Experimentia 32:336–338.
Onishi, H., Soma, T., Yamagami, S., and Kawakita, Y. 1989. Alteration of opioid receptors in seizure-susceptible El mouse brain. Neurochem. Res. 14:31–35.
Onishi, H., Koide, S., Yamagami, S., and Kawakita, Y. 1990. Developmental and regional alteration of methionine enkephalin-like immunoreactivity in seizure-susceptible El mouse brain. Neurochem. Res. 15:83–87.
Ueda, H., Amano, H., Shiomi, H., and Takagi, H. 1979. Comparison of the analgesic effects of various opioid peptides by a newly devised intracisternal injection technique in conscious mice. Eur. J. Pharmacol. 56:265–268.
Dingledine, R., Iversen, L. L., and Breuker, E. 1978. Naloxone as a GABA antagonist: Evidence from iontophoretic receptor binding and convulsant studies. Eur. J. Pharmacol. 47:19–27.
Werz, M. A., and MacDonald, R. L. 1982. Opiate alkaloids antagonize postysynaptic glycine and GABA responses: Correlation with convulsant action. Brain Res. 236:107–119.
Banks, W. A., and Kastin, A. J. 1987. Saturable transport of peptides across the blood-brain barrier. Life Sci. 41:1319–1338.
Banks, W. A., and Kastin, A. J. 1990. Peptide transport systems for opiates across the blood-brain barrier. Am. J. Physiol. 259:E1–10.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koide, S., Onishi, H., Yamagami, S. et al. Effects of morphine andd-Ala2-d-Leu5-enkephalin in the seizure-susceptible El mouse. Neurochem Res 17, 779–783 (1992). https://doi.org/10.1007/BF00969012
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00969012